Compounds > staurosporine
Page last updated: 2024-08-23

staurosporine and mitoxantrone

staurosporine has been researched along with mitoxantrone in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (62.50)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aravena, Mde L; Bruno, AM; Cabrera, M; Cascante, M; Cerecetto, H; González, M; Lavaggi, ML; López de Ceráin, A; Monge, A; Olea-Azar, C; Pachón, G; Pietrasanta, LI1
Bellosillo, B; Bosch, F; Campo, E; Colomer, D; Espinet, B; Ferrer, A; López-Guillermo, A; Marcé, S; Montserrat, E; Solé, F; Villamor, N1
Hua, DH; Lou, K; Perchellet, EM; Perchellet, JP; Wang, Y; Ward, MM1
Sikorski, AF; Stebelska, K; Wyrozumska, P1
Akutsu, M; Furukawa, Y; Izumi, T; Kano, Y; Kirito, K; Mano, H; Matsuo, Y; Odgerel, T; Sato, Y; Tsunoda, S; Vu, HA1
Karp, J1
Adjemian, S; Chaba, K; Galluzzi, L; Kepp, O; Kroemer, G; Lemaire, M; Pype, J; Rello-Varona, S; Spaggiari, S1
Bhatnagar, B; Blum, W; Canning, R; Devine, SM; Garzon, R; Geyer, S; Klisovic, R; Marcucci, G; Vasu, S; Walker, AR; Walsh, K; Wang, H; Wu, YZ1

Other Studies

8 other study(ies) available for staurosporine and mitoxantrone

ArticleYear
Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation.
    Bioorganic & medicinal chemistry, 2010, Jun-15, Volume: 18, Issue:12

    Topics: Animals; Antineoplastic Agents; Caco-2 Cells; Cell Hypoxia; Cell Line; Colonic Neoplasms; Cricetinae; DNA Damage; DNA Fragmentation; Humans; Phenazines

2010
Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes.
    Oncogene, 2004, Nov-25, Volume: 23, Issue:55

    Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Coloring Agents; Cyclophosphamide; DNA Damage; Enzyme Inhibitors; Flow Cytometry; Genes, p53; Humans; In Situ Hybridization, Fluorescence; Leukocytes, Mononuclear; Lymphoma, Mantle-Cell; Membrane Potentials; Mitochondria; Mitoxantrone; Proteins; Reactive Oxygen Species; Staurosporine; Time Factors; Translocation, Genetic; Tumor Suppressor Protein p53; Vidarabine

2004
Rapid collapse of mitochondrial transmembrane potential in HL-60 cells and isolated mitochondria treated with anti-tumor 1,4-anthracenediones.
    Anti-cancer drugs, 2005, Volume: 16, Issue:9

    Topics: Alamethicin; Animals; Anthraquinones; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bongkrekic Acid; Calcium Chloride; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cyclosporine; Cysteine Proteinase Inhibitors; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Female; Gramicidin; HL-60 Cells; Humans; Intracellular Membranes; Ion Channels; Membrane Potentials; Mice; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitoxantrone; Ruthenium Red; Staurosporine; Ubiquinone

2005
PS exposure increases the susceptibility of cells to fusion with DOTAP liposomes.
    Chemico-biological interactions, 2006, Mar-25, Volume: 160, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Cell Membrane; Chlorides; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluorescent Dyes; HeLa Cells; Humans; Jurkat Cells; Liposomes; Manganese Compounds; Membrane Fusion; Mitoxantrone; Phosphatidylserines; Phospholipid Transfer Proteins; Quaternary Ammonium Compounds; Staurosporine; Vidarabine

2006
Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus -negative leukemia cell lines.
    Leukemia, 2007, Volume: 21, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line, Tumor; Cytarabine; Doxorubicin; Etoposide; fms-Like Tyrosine Kinase 3; Humans; Idarubicin; Leukemia; Methotrexate; Mitoxantrone; Mutation; Protein Kinase C; Staurosporine

2007
Future research directions for the treatment of AML.
    Clinical advances in hematology & oncology : H&O, 2008, Volume: 6, Issue:11

    Topics: Antineoplastic Agents; Azacitidine; Biomedical Research; Carbazoles; Carboplatin; Cytarabine; Daunorubicin; Decitabine; Enzyme Inhibitors; Etoposide; Flavonoids; Furans; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Piperidines; Quinolones; Staurosporine; Topotecan; Tretinoin

2008
Antiapoptotic activity of argon and xenon.
    Cell cycle (Georgetown, Tex.), 2013, Aug-15, Volume: 12, Issue:16

    Topics: Apoptosis; Argon; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Cytochromes c; Cytoprotection; Humans; Microscopy, Fluorescence; Mitoxantrone; Staurosporine; Xenon

2013
Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia.
    Leukemia & lymphoma, 2016, Volume: 57, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Chromosome Aberrations; Cytarabine; Drug Monitoring; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Mitoxantrone; Recurrence; Remission Induction; Retreatment; Staurosporine; Treatment Outcome; Young Adult

2016